Search details
1.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37769952
2.
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial.
Hepatology
; 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38536017
3.
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
Gut
; 2024 Apr 03.
Article
in English
| MEDLINE | ID: mdl-38569845
4.
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
Am J Transplant
; 24(5): 733-742, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38387623
5.
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B.
J Hepatol
; 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38527527
6.
Endocuff With or Without Artificial Intelligence-Assisted Colonoscopy in Detection of Colorectal Adenoma: A Randomized Colonoscopy Trial.
Am J Gastroenterol
; 2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38305278
7.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38483300
8.
Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
Hepatology
; 77(5): 1735-1745, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36111362
9.
Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
Hepatology
; 77(2): 606-618, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36130882
10.
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
J Gastroenterol Hepatol
; 39(1): 202-209, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37794699
11.
Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease.
Hepatobiliary Pancreat Dis Int
; 23(3): 241-248, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-37620227
12.
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVac.
Int J Mol Sci
; 25(5)2024 Feb 23.
Article
in English
| MEDLINE | ID: mdl-38473829
13.
Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal Expansion.
Clin Infect Dis
; 76(3): e801-e809, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-35594553
14.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Article
in English
| MEDLINE | ID: mdl-35863683
15.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34762906
16.
Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety.
Am J Gastroenterol
; 2023 Aug 10.
Article
in English
| MEDLINE | ID: mdl-37561058
17.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-36719174
18.
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study.
J Viral Hepat
; 30(4): 319-326, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36606597
19.
Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy.
Virol J
; 20(1): 168, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37528444
20.
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Helicobacter
; 28(4): e12972, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36965192